Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

What if I don’t want to carry on with ASCEND PLUS?

We hope you will be able to continue with the study treatment for the full course of the trial.

If you choose to stop the study medication, it would be helpful if you could continue to complete the six-monthly questionnaires. However, you may decide you no longer wish to, or are no longer able to stay in contact with the study team. With your consent at the start of the study, the study scientists can also get information about your health from NHS organisations such as NHS England or other NHS bodies and health registries. If you would like us to stop collecting information about your health from these organisations you can contact the study team at any time. However, data already received by the study would still be analysed to make sure that the study produces reliable results.  

You are free to stop taking part in this study at any time without this having any effect on your future medical care.

Can I join this study?

Yes, potentially, if you:

  • have received a written invitation from the ASCEND PLUS study team
  • are aged 55 years or above
  • have type 2 diabetes mellitus.

If you have a history of any of the following, you are not able to join the trial:

  • previous heart attack or stroke
  • current or planned treatment with oral semaglutide or similar type of drug: Semaglutide injections (Ozempic ® or Wegovy ®); Dulaglutide (Trulicity ®); Exenatide (Byetta ®); Liraglutide (Victoza ® or Saxenda®); Lixisenatide (Lyxumia ®) 
  • previous allergy or intolerance to oral semaglutide or similar type of drug
  • low blood sugar (a ‘hypo’) for which you have needed help from another person (e.g. if you had to go to A&E or needed emergency treatment from a paramedic, friend or relative) in the last 6 months
  • low blood sugar (a ‘hypo’) causing symptoms in the past month
  • are in the process of starting insulin treatment
  • current or planned kidney dialysis
  • severe heart failure with difficulty breathing at rest
  • type 1 diabetes or other types of diabetes (e.g. Mature Onset Diabetes of the Young, MODY)
  • ongoing treatment for cancer, or a diagnosis of cancer within the last two years (some skin cancers do not affect ability to join the trial)
  • current or planned pregnancy or currently breastfeeding
  • a particular type of thyroid cancer called medullary thyroid cancer – if you have been diagnosed with thyroid cancer you can speak to a study doctor to check whether you could join the trial
  • any serious medical condition which is likely to make it difficult for you to take part
  • current participation in a clinical trial which is testing an unlicensed medication for diabetes.

To speak to one of the study doctors or nurses about whether you are able to join the trial, please contact the ASCEND PLUS team. 

Find out more

Read this information leaflet for further details.